Discount Code (0% Off) has been applied.
 
Enter a search term.

If you can't find what you were looking for, please contact us using one of the methods below so we can better serve you.

1 (800) 854-7220
answers@mcguff.com Suggest an Item
Manufacturer: Claris

..

Furosemide 10mgmL SDV 2mL Vial
Furosemide 10mgmL SDV 2mL Vial
Furosemide 10mgmL SDV 2mL Vial
Furosemide 10mgmL SDV 2mL Vial
Manufacturer: Claris (Shop the Brand)

Furosemide Injection 10 mg/mL, Single Dose Vial 2mL, Each

Item Code: 000649
Mfg Part #: 36000-0282-25
$4.62
This product has expiring stock at a discounted price. Click for more savings!
Requires Verified Medical License to Purchase
Unsupported attribute type: 0
To reduce overall packaging and shipping costs, our shipping department will pack your orders in as few boxes as possible. Compounded drugs must ship separately from our other products. When choosing Next Day or 2nd Day Air shipping methods, final shipping totals will be calculated when your order is packed and invoiced. Box size and package destination does not affect shipping fee calculations. The number of boxes is determined by size, weight and quantity of products ordered. For additional information or questions, please contact us.
About This Product

..

Products specifications
Medical License Required Yes
Class Rx Only
Product Name Injection
Generic Name Furosemide
Route of Administration Intravenous (IV), Intramuscular (IM)
Strength 10 mg/mL
Volume 2 mL
Container Single Dose Vial
Storage Requirements USP Controlled Room Temperature
Storage Temperature 20º to 25ºC (68 to 77ºF)
Therapeutic Class Diuretic/Cardiovascular

Furosemide Injection, USP is a sterile, non-pyrogenic loop diuretic solution (10 mg/mL) indicated for intravenous (IV) and intramuscular (IM) administration. It is indicated for the treatment of edema associated with congestive heart failure, hepatic cirrhosis, and renal disease—including nephrotic syndrome—in adult and pediatric patients.

Furosemide Injection is also indicated as adjunctive therapy in acute pulmonary edema where rapid onset of diuresis is required.

Key Benefits

  • Broad Edema Indications: Indicated for edema associated with congestive heart failure, hepatic cirrhosis, and renal disease including nephrotic syndrome in both adults and pediatric patients.
  • Rapid Diuretic Onset: IV administration produces diuretic effect within 5 minutes of injection for urgent fluid management needs.
  • Acute Pulmonary Edema Support: Indicated as adjunctive therapy when rapid fluid reduction is clinically required.
  • Potent Diuretic Option: Particularly useful when an agent with greater diuretic potential is desired over standard therapies.
  • Sterile Single-Dose Formulation: Available as a preservative-free, non-pyrogenic solution for IV or IM use.

Dosage and Administration

Furosemide Injection, USP is for intravenous or intramuscular use. Administer IV doses slowly over 1 to 2 minutes.

  • Adult Edema (Initial Dose): 20–40 mg IV or IM; dose may be raised by 20 mg increments no sooner than 2 hours after the previous dose until the desired diuretic effect is achieved, then administered once or twice daily.
  • Acute Pulmonary Edema: 40 mg IV; if response is inadequate after 1 hour, increase to 80 mg IV.
  • Pediatric Patients: 1 mg/kg body weight given slowly; doses greater than 6 mg/kg are not recommended.
  • Geriatric Patients: Initiate at the low end of the dosing range with careful monitoring.

Why Choose Furosemide Injection, USP?

Furosemide Injection, USP provides a rapid-onset parenteral option for patients unable to take oral medication or requiring emergency diuresis. IV administration produces diuretic effect within 5 minutes, making it a clinically essential tool for acute fluid management in critical care settings.

Warnings

  • Electrolyte Depletion Risk: Furosemide is a potent diuretic; excessive doses can cause profound diuresis with water and electrolyte depletion. Careful medical supervision and individualized dose adjustment are required.
  • Ototoxicity: Cases of tinnitus and reversible or irreversible hearing impairment have been reported, particularly with rapid injection, severe renal impairment, supratherapeutic doses, or concomitant use of aminoglycoside antibiotics or other ototoxic drugs.
  • Hepatic Cirrhosis Caution: Sudden fluid and electrolyte shifts may precipitate hepatic coma in cirrhotic patients; do not initiate therapy in states of electrolyte depletion until the underlying condition is corrected.

Disclaimer: This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.
Products specifications
Furosemide Injection 10 mgmL Single Dose Vial 2mL 25Tray
Furosemide 10mgmL SDV 2mL 25 VialsTray
Furosemide 10mgmL SDV 2mL 25 VialsTray
Manufacturer: Claris (Shop the Brand)

Furosemide Injection 10 mg/mL, Single Dose Vial 2mL, 25/Tray

Item Code: 009507
Mfg Part #: 36000-0282-25
$103.95
This product has expiring stock at a discounted price. Click for more savings!
Requires Verified Medical License to Purchase
Unsupported attribute type: 0
To reduce overall packaging and shipping costs, our shipping department will pack your orders in as few boxes as possible. Compounded drugs must ship separately from our other products. When choosing Next Day or 2nd Day Air shipping methods, final shipping totals will be calculated when your order is packed and invoiced. Box size and package destination does not affect shipping fee calculations. The number of boxes is determined by size, weight and quantity of products ordered. For additional information or questions, please contact us.
About This Product

..

Products specifications
Medical License Required Yes
Class Rx Only
Product Name Injection
Generic Name Furosemide
Route of Administration Intravenous (IV), Intramuscular (IM)
Strength 10 mg/mL
Volume 2 mL
Container Single Dose Vial
Storage Requirements USP Controlled Room Temperature
Storage Temperature 20º to 25ºC (68 to 77ºF)
Therapeutic Class Diuretic/Cardiovascular

Furosemide Injection, USP is a sterile, non-pyrogenic loop diuretic solution (10 mg/mL) indicated for intravenous (IV) and intramuscular (IM) administration. It is indicated for the treatment of edema associated with congestive heart failure, hepatic cirrhosis, and renal disease—including nephrotic syndrome—in adult and pediatric patients.

Furosemide Injection is also indicated as adjunctive therapy in acute pulmonary edema where rapid onset of diuresis is required.

Key Benefits

  • Broad Edema Indications: Indicated for edema associated with congestive heart failure, hepatic cirrhosis, and renal disease including nephrotic syndrome in both adults and pediatric patients.
  • Rapid Diuretic Onset: IV administration produces diuretic effect within 5 minutes of injection for urgent fluid management needs.
  • Acute Pulmonary Edema Support: Indicated as adjunctive therapy when rapid fluid reduction is clinically required.
  • Potent Diuretic Option: Particularly useful when an agent with greater diuretic potential is desired over standard therapies.
  • Sterile Single-Dose Formulation: Available as a preservative-free, non-pyrogenic solution for IV or IM use.

Dosage and Administration

Furosemide Injection, USP is for intravenous or intramuscular use. Administer IV doses slowly over 1 to 2 minutes.

  • Adult Edema (Initial Dose): 20–40 mg IV or IM; dose may be raised by 20 mg increments no sooner than 2 hours after the previous dose until the desired diuretic effect is achieved, then administered once or twice daily.
  • Acute Pulmonary Edema: 40 mg IV; if response is inadequate after 1 hour, increase to 80 mg IV.
  • Pediatric Patients: 1 mg/kg body weight given slowly; doses greater than 6 mg/kg are not recommended.
  • Geriatric Patients: Initiate at the low end of the dosing range with careful monitoring.

Why Choose Furosemide Injection, USP?

Furosemide Injection, USP provides a rapid-onset parenteral option for patients unable to take oral medication or requiring emergency diuresis. IV administration produces diuretic effect within 5 minutes, making it a clinically essential tool for acute fluid management in critical care settings.

Warnings

  • Electrolyte Depletion Risk: Furosemide is a potent diuretic; excessive doses can cause profound diuresis with water and electrolyte depletion. Careful medical supervision and individualized dose adjustment are required.
  • Ototoxicity: Cases of tinnitus and reversible or irreversible hearing impairment have been reported, particularly with rapid injection, severe renal impairment, supratherapeutic doses, or concomitant use of aminoglycoside antibiotics or other ototoxic drugs.
  • Hepatic Cirrhosis Caution: Sudden fluid and electrolyte shifts may precipitate hepatic coma in cirrhotic patients; do not initiate therapy in states of electrolyte depletion until the underlying condition is corrected.

Disclaimer: This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.
Products specifications
Brands in this category
Picture for manufacturer American Regent
Picture for manufacturer Exela
Picture for manufacturer Hospira
Picture for manufacturer McGuff Pharmaceuticals
Picture for manufacturer Mylan

Featured Articles

McGuff’s Promise of Quality and Service

For over 50 years, we’ve been the trusted name in healthcare excellence. Medical practitioners can rely on us for quality products, fast deliveries, and superior service. We strive for customer satisfaction and maintaining that trust.

We at the McGuff Company, Inc. (McGuff) work very hard to provide you accurate and timely information on our website. However, it is your obligation to verify such information before using the products purchased from McGuff.

All information is provided “As-is” and may change without prior notice. McGuff does not make warranty or representation that the information contained on this site is accurate, current, or complete.

Any use of information by you is without recourse to McGuff and is at your own risk.

McGuff is in no way responsible for any damages whether direct, consequential, incidental, or otherwise suffered by you or others on your behalf as a result of using or relying upon such information for any purpose.

Products specifications
Medical License Required Yes
Class Rx Only
Product Name Injection
Generic Name Furosemide
Route of Administration Intravenous (IV), Intramuscular (IM)
Strength 10 mg/mL
Volume 2 mL
Container Single Dose Vial
Storage Requirements USP Controlled Room Temperature
Storage Temperature 20º to 25ºC (68 to 77ºF)
Therapeutic Class Diuretic/Cardiovascular

Contact Us

McGuff Company is LegitScript Certified

Copyright © 2026 McGuff Company, Inc. All rights reserved.

For information on the duties and responsibilities of this web site, please read our privacy policy and our warning and disclaimer . Use of this website signifies your agreement to the Privacy Policy and Warning Disclaimer.

Coronavirus (COVID-19)

Due to the Coronavirus (COVID-19) outbreak worldwide, the global demand for some Personal Protective Equipment (PPE) is exceeding current supply availability.

In addition, the manufacturing of the PPE and many other wound care/infection prevention products have been impacted by the global response to the Coronavirus. While you may see product availability reduction in the near-term, please be assured that we at McGuff Medical are continuing to work diligently to ensure an uninterrupted supply of products and alternative products to you.

Additionally, in order to ensure healthcare providers have access to the PPEs they need, the McGuff Company is temporarily limiting PPEs to healthcare providers.

As always, please feel free to reach out to our McGuff Customer Service team with any questions that you may have.

Click here for updates regarding Coronavirus Pandemic and Your Supplies and a message from our President